71 related articles for article (PubMed ID: 17884766)
21. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH
Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872
[TBL] [Abstract][Full Text] [Related]
22. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
[TBL] [Abstract][Full Text] [Related]
23. 53BP1, an activator of ATM in response to DNA damage.
Mochan TA; Venere M; DiTullio RA; Halazonetis TD
DNA Repair (Amst); 2004; 3(8-9):945-52. PubMed ID: 15279780
[TBL] [Abstract][Full Text] [Related]
24. Differences in DNA double strand breaks repair in male germ cell types: lessons learned from a differential expression of Mdc1 and 53BP1.
Ahmed EA; van der Vaart A; Barten A; Kal HB; Chen J; Lou Z; Minter-Dykhouse K; Bartkova J; Bartek J; de Boer P; de Rooij DG
DNA Repair (Amst); 2007 Sep; 6(9):1243-54. PubMed ID: 17376750
[TBL] [Abstract][Full Text] [Related]
25. MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression.
Zou R; Zhong X; Wang C; Sun H; Wang S; Lin L; Sun S; Tong C; Luo H; Gao P; Li Y; Zhou T; Li D; Cao L; Zhao Y
Int J Biol Sci; 2015; 11(9):992-1005. PubMed ID: 26221067
[TBL] [Abstract][Full Text] [Related]
26. [The expression and significance of major histocompatibility complex II transactivator gene in five human malignant hematological cell lines].
You Y; Zou P; Guo R
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):288-91. PubMed ID: 15130416
[TBL] [Abstract][Full Text] [Related]
27. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
28. [Effect on retardation of G2/M phase in esophageal carcinoma cells transfected with CHK1 and CHK2 shRNA after irradiation].
Wang YX; Zhu SC; Feng W; Li J; Su JW; Li R
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):572-7. PubMed ID: 17236549
[TBL] [Abstract][Full Text] [Related]
29. An investigation into 53BP1 complex formation.
Roche KC; Lowndes NF
Adv Exp Med Biol; 2007; 604():47-57. PubMed ID: 17695720
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of the p53 protein in cell lines derived from human esophageal cancers.
Barnas C; Martel-Planche G; Furukawa Y; Hollstein M; Montesano R; Hainaut P
Int J Cancer; 1997 Mar; 71(1):79-87. PubMed ID: 9096669
[TBL] [Abstract][Full Text] [Related]
31. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
Xiao Y; Zheng X; Huang A; Liu T; Zhang T; Ma H
Int J Oncol; 2016 Oct; 49(4):1600-8. PubMed ID: 27499037
[TBL] [Abstract][Full Text] [Related]
33. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.
DiTullio RA; Mochan TA; Venere M; Bartkova J; Sehested M; Bartek J; Halazonetis TD
Nat Cell Biol; 2002 Dec; 4(12):998-1002. PubMed ID: 12447382
[TBL] [Abstract][Full Text] [Related]
34. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
Zhao R; Quaroni L; Casson AG
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
[TBL] [Abstract][Full Text] [Related]
37. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.
Wang JL; Yu JP; Sun ZQ; Sun SP
World J Gastroenterol; 2014 Dec; 20(48):18296-305. PubMed ID: 25561796
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation.
Jing SW; Wang YD; Chen LQ; Sang MX; Zheng MM; Sun GG; Liu Q; Cheng YJ; Yang CR
Dis Esophagus; 2013 Jan; 26(1):75-83. PubMed ID: 22340517
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Dis Esophagus; 2006; 19(6):454-8. PubMed ID: 17069588
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells.
Yang Z; Bu Y; Wang C; Liu G; Song F
Mol Cell Biochem; 2010 Sep; 342(1-2):1-6. PubMed ID: 20364298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
